Molly Went

9PUBLICATIONS
42CO-AUTHORS
Cancer geneticsHaematological tumoursMedical infection agents (incl. prions)Gene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 01, 2025
Deciphering genetic susceptibility to clear cell renal cell carcinoma.

Maria Mandelia, Philip J Law, Charlie Mills

|Sep 02, 2025
Mendelian randomisation analysis to discover plasma metabolites mediating the effect of obesity on cancer risk.

Thomas Yates, Molly Went, Charlie Mills

|Apr 08, 2025
Mendelian randomization of immune cell phenotypes to discover potential drug targets for B-cell malignancy.

Sina A Beer, Molly Went, Charlie Mills

|Aug 05, 2024
Deciphering the genetics and mechanisms of predisposition to multiple myeloma.

Molly Went, Laura Duran-Lozano, Gisli H Halldorsson

|Mar 26, 2024
Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancers.

Molly Went, Amit Sud, Charlie Mills

|Aug 21, 2019
Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes.

Molly Went, Ben Kinnersley, Amit Sud

Pageof 2

Frequent Collaborators

7 joint publications

Richard S Houlston

5 joint publications

Philip Law

4 joint publications

Amit Sud

4 joint publications

Charlie Mills